Origin Life Sciences, Inc. — Form D

Origin Life Sciences, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-15. The offering totals $22.5M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
David David Dantzker, MDDirectorPrinceton, NJ
David David Dantzker, MDExecutive OfficerPrinceton, NJ
Betsy David HannaExecutive OfficerPrinceton, NJ
Howard David NelsonExecutive OfficerPrinceton, NJ
Michael David PrestonDirectorPrinceton, NJ
Michael David PrestonExecutive OfficerPrinceton, NJ
Jerome Boda KortenDirectorPrinceton, NJ
Victor David MicatiDirectorPrinceton, NJ
David David DantzkerDirectorPrinceton, NJ
David David DantzkerExecutive OfficerPrinceton, NJ
John David FernandesExecutive OfficerPrinceton, NJ
Anthony David BramptonDirectorPrinceton, NJ
Alex David Dolgopolsky, PhDExecutive OfficerPrinceton, NJ
Howard David NelsonDirectorPrinceton, NJ
Tony David BramptonDirectorPrinceton, NJ
Johnny David FernandesExecutive OfficerPrinceton, NJ
Vic David MicatiDirectorPrinceton, NJ
Mike David PohlExecutive OfficerPrinceton, NJ
Michael David PohlExecutive OfficerLawrenceville, NJ
Alex David Dolgopolsky, MDExecutive OfficerLawrenceville, NJ
Issac David Anthony IIIExecutive OfficerLawrenceville, NJ

Other filings by this issuer (5)

FiledFormOfferingSold
2023-10-17D$5.0M$51K
2023-06-22D/A$850K$660K
2023-06-01D$850K$500K
2022-09-07D$5.0M$500K
2013-04-08D$2.5M$500K

More